Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Infectious Disease Research

Study Title:  A Study of CB-183,315 in Patients with Clostridium Difficile Associated Diarrhea (Identifier: NCT01598311).

Study Purpose:  608 patients with Clostridium Difficile Associated Diarrhea (CDAD) will participate in this study and receive either oral vancomycin or CB-183,315 in a blinded fashion. Treatment will last for 10 days and participants will be followed up for at least 40 days and a maximum of 100 days. The purpose of this study is to evaluate how well CB-183,315 treats CDAD as compared to vancomycin

Principal Investigator: Joan Duggan, M.D.

Study Coordinator:  Nicole Amadio, or call for more info at 419-383-4387

Last Updated: 6/17/14